rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jennifer Fulk

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, Kura Oncology; Chief Financial Officer, Soleno Therapeutics; Chief Financial Officer, Talkspace.

In numbers

Trades disclosed
24
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
3
Companies where not an officer
0
First trade
26 Jul 2021
Last trade
8 Sep 2026
Last filed
10 Sep 2026

Companies traded

Where they are an officer
KURA Kura OncologyOfficer · Biotechnology · last 8 Sep 20260 buys · 0 sells
Soleno TherapeuticsOfficer · Biotechnology · last 18 May 20260 buys · 0 sells
TalkspaceOfficer · Providers & Facilities · last 6 Mar 20240 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
8 Sep 2026filed 10 Sep 2026KURA Kura Oncologyoption or derivative · BiotechnologySEC FORM 4 Code A—450,000 at $0.00filing
8 Sep 2026filed 10 Sep 2026KURA Kura Oncologyoption or derivative · BiotechnologySEC FORM 4 Code A—450,000 at $0.00filing
18 May 2026filed 18 May 2026Soleno TherapeuticsBiotechnologySEC FORM 4 Code D—39,200filing
18 May 2026filed 18 May 2026Soleno Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—67,660filing
18 May 2026filed 18 May 2026Soleno Therapeuticsoption or derivativeSEC FORM 4 Code D—67,660filing
18 May 2026filed 18 May 2026Soleno TherapeuticsSEC FORM 4 Code D—39,200filing
2 Mar 2026filed 4 Mar 2026Soleno TherapeuticsBiotechnologySEC FORM 4 Code A—39,200 at $0.00filing
2 Mar 2026filed 4 Mar 2026Soleno Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code M—67,660 at $0.00filing
2 Mar 2026filed 4 Mar 2026Soleno Therapeuticsoption or derivativeSEC FORM 4 Code M—67,660 at $0.00filing
2 Mar 2026filed 4 Mar 2026Soleno TherapeuticsSEC FORM 4 Code A—39,200 at $0.00filing
6 Mar 2024filed 8 Mar 2024TalkspaceProviders & FacilitiesSEC FORM 4 Code F$7,8402,622 at $2.99filing
6 Mar 2024filed 8 Mar 2024TalkspaceProviders & FacilitiesSEC FORM 4 Code F$22K7,297 at $2.99filing
6 Mar 2024filed 8 Mar 2024TalkspaceProviders & FacilitiesSEC FORM 4 Code F$24K7,908 at $2.99filing
1 Mar 2024filed 5 Mar 2024Talkspaceoption or derivative · Providers & FacilitiesSEC FORM 4 Code A—74,205 at $0.00filing
1 Mar 2024filed 5 Mar 2024TalkspaceProviders & FacilitiesSEC FORM 4 Code A—178,695 at $0.00filing
1 Mar 2023filed 5 Mar 2024Talkspaceoption or derivative · Providers & FacilitiesSEC FORM 4 Code A—47,616 at $0.00filing
1 Mar 2023filed 5 Mar 2024TalkspaceProviders & FacilitiesSEC FORM 4 Code A—431,494 at $0.00filing
2 Sep 2022filed 8 Sep 2022TalkspaceProviders & FacilitiesSEC FORM 4 Code F$8,2106,173 at $1.33filing
2 Sep 2022filed 8 Sep 2022TalkspaceProviders & FacilitiesSEC FORM 4 Code F$12K8,873 at $1.33filing
2 Jun 2022filed 6 Jun 2022TalkspaceProviders & FacilitiesSEC FORM 4 Code F—6,173 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Kathleen FordChief Operating Officer · Chief Operating Officer at Kura Oncology, filing Form 4 there in the last year
Brian T. PowlChief Commercial Officer · Chief Commercial Officer at Kura Oncology, filing Form 4 there in the last year
Thomas James DoyleSVP, Finance & Accounting · SVP, Finance & Accounting at Kura Oncology, filing Form 4 there in the last year
Teresa Brophy BairChief Legal Officer · Chief Legal Officer at Kura Oncology, filing Form 4 there in the last year
Mollie LeoniChief Medical Officer · Chief Medical Officer at Kura Oncology, filing Form 4 there in the last year